Maryam Mirshams
Maryam Mirshams
Princess Margaret Hospital, University of Toronto
Verified email at
Cited by
Cited by
Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk
G Liu, S Gramling, D Munoz, D Cheng, AK Azad, M Mirshams, Z Chen, ...
Oncogene 30 (29), 3295-3304, 2011
Validation of Genetic Sequence Variants as Prognostic Factors in Early-Stage Head and Neck Squamous Cell Cancer SurvivalGenetic Sequence Variants and Head and Neck Cancer Survival
AK Azad, I Bairati, E Samson, D Cheng, M Mirshams, X Qiu, S Savas, ...
Clinical Cancer Research 18 (1), 196-206, 2012
Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk
JR Wang, SJB Gramling, DP Goldstein, D Cheng, D Chen, AK Azad, ...
Carcinogenesis 34 (5), 1012-1017, 2013
Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada
KP Chu, S Habbous, Q Kuang, K Boyd, M Mirshams, FF Liu, ...
Cancer epidemiology 40, 102-112, 2016
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers
AK Azad, I Bairati, E Samson, D Cheng, L Cheng, M Mirshams, S Savas, ...
Cancer 118 (6), 1554-1565, 2012
Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire
K Hueniken, CM Douglas, AR Jethwa, M Mirshams, L Eng, A Hope, ...
Cancer 126 (17), 4042-4050, 2020
Two BRM promoter insertion polymorphisms increase the risk of early‐stage upper aerodigestive tract cancers
KM Wong, X Qiu, D Cheng, AK Azad, S Habbous, P Palepu, M Mirshams, ...
Cancer Medicine 3 (2), 426-433, 2014
Multiple imputation and clinico‐serological models to predict human papillomavirus status in oropharyngeal carcinoma: an alternative when tissue is unavailable
J Ren, W Xu, J Su, X Ren, D Cheng, Z Chen, N Bender, M Mirshams, ...
International journal of cancer 146 (8), 2166-2174, 2020
HPV status improves classification of head and neck gray zone cancers
J Ren, W Xu, J Su, X Ren, N Bender, S Habbous, JR de Almeida, ...
Journal of Dental Research 98 (8), 879-887, 2019
Two BRM promoter polymorphisms and risk of early stage (Stage I-II) upper aerodigestive tract cancer risk
K Wong, X Qiu, D Cheng, AK Azad, P Palepu, M Mirshams, D Patel, ...
J Clin Oncol 30 (Suppl), 2012
The effect of two BRM promoter variants on the risk of stage I/II upper aerodigestive tract cancers.
KM Wong, X Qiu, D Cheng, AK Azad, PR Palepu, M Mirshams, D Patel, ...
Journal of Clinical Oncology 30 (15_suppl), 10522-10522, 2012
Out‐of‐pocket costs associated with head and neck cancer treatment
MN Khan, K Hueniken, M Manojlovic‐Kolarski, L Eng, M Mirshams, ...
Cancer Reports 5 (7), e1528, 2022
Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis
S Thomas, JC Carroll, MC Brown, Z Chen, M Mirshams, D Patel, K Boyd, ...
Plos one 15 (8), e0237723, 2020
Association between genetic variants and cisplatin-induced nephrotoxicity: a genome-wide approach and validation study
Z Zazuli, C de Jong, W Xu, SJH Vijverberg, R Masereeuw, D Patel, ...
Journal of Personalized Medicine 11 (11), 1233, 2021
A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways
AK Azad, I Bairati, X Qiu, H Girgis, L Cheng, D Waggott, D Cheng, ...
Cancer Epidemiology 42, 173-180, 2016
The basket or umbrella real-world observational study (BUROS) design for molecular cancer subtypes
G Liu, S Raptis, M Mirshams, D Patel, S Chotai, A Ghattas, A Zarrin, A Stitt, ...
947P Association between genetic variants and cisplatin nephrotoxicity: A genome-wide approach
Z Zazuli, W Xu, S Vijverberg, R Masereeuw, M Mirshams, K Khan, ...
Annals of Oncology 31, S674, 2020
Cisplatin-induced ototoxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation: The role of WFS1 and ABCC2 heritable variants.
M Mahler, Y Zhang, K Hueniken, MC Brown, Z Chen, M Mirshams, ...
Journal of Clinical Oncology 36 (15_suppl), 6048-6048, 2018
The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic
V Ho, Y Song, C Brown, A Vennettilli, L Eng, A Zarrin, A Dobriyal, L Chen, ...
Value in Health 18 (7), A470-A471, 2015
Using tablet technology in routine patient-reported outcome measure surveys to improve cancer quality care: A patient acceptability assessment.
V Pat, C Brown, A Vennettilli, A Zarrin, A Dobriyal, L Chen, M Mirshams, ...
Journal of Clinical Oncology 32 (30_suppl), 155-155, 2014
The system can't perform the operation now. Try again later.
Articles 1–20